News
Boston-based Verve is a rare example of a gene editing company targeting a disease that affects a large population, offering ...
The stylist behind Jenna Bush Hager’s bob haircut shares his secrets, are GLP-1 drugs or bariatric surgery better for weight ...
Salmonella Outbreak Tied To Pistachio Cream Sickens People In 2 States The US Centers for Disease Control and Prevention (CDC) on June 13 announced a Salmonella Oraneinburg outbreak linked to ...
Eli Lilly's stock price has over-corrected following a downgrade in its outlook following the adjustment for acquisition ...
Eli Lilly is acquiring Verve Therapeutics to strengthen its cardiovascular pipeline with a gene-editing drug targeting PCSK9-linked conditions.
Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...
2h
WISH-TV on MSNLilly to begin direct Zepbound shipmentsLilly will start shipping Zepbound to cash-paying customers, gas prices are rising, At Home has filed for bankruptcy, and ...
When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.
Innovent completes first patient dosing in seventh phase 3 trial (GLORY-OSA) of mazdutide in China with moderate-to-severe OSA & obesity: San Francisco, US Tuesday, June 17, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results